ROYAL BANK OF CANADA - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$0
-100.0%
1
-99.9%
0.00%
Q2 2020$1,0007730.0%0.00%
Q1 2020$0773
+2315.6%
0.00%
Q3 2019$0
-100.0%
32
-94.6%
0.00%
Q3 2018$3,000
+50.0%
595
+143.9%
0.00%
Q2 2018$2,000
+100.0%
244
+128.0%
0.00%
Q1 2018$1,0000.0%107
+7.0%
0.00%
Q4 2017$1,000
-90.0%
100
-90.8%
0.00%
Q3 2017$10,0001,090
+12011.1%
0.00%
Q2 2017$090.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
CVI Holdings, LLC 92,200$646,0000.88%
683 Capital Management, LLC 500,000$3,505,0000.31%
BIEGEL & WALLER LLC 66,508$466,0000.30%
Monashee Investment Management LLC 94,000$659,0000.18%
Aveo Capital Partners, LLC 16,732$117,0000.05%
Artal Group S.A. 500,000$3,505,0000.04%
Radnor Capital Management, LLC 10,000$70,0000.02%
Tower Research Capital LLC (TRC) 12,672$89,0000.01%
Trexquant Investment LP 15,757$110,0000.01%
FMR LLC 4,332,888$30,374,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders